TCONUnknownMicro-Cap
Tracon Pharmaceuticals, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Tracon Pharmaceuticals, Inc. (TCON), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TCON insiders buying or selling?
Tracon Pharmaceuticals, Inc. insiders reported 87 open-market buys ($13.3M) and 4 sells ($2.5M) across 91 Form 4 filings — a net buying position of $10.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 14, 2023)
Total Form 4 filings
91
SEC EDGAR
Insider filers
8
Insider buys (87)
$13.3M
Insider sells (4)
$2.5M
Insider sentiment
Net buyingNet insider flow of $10.8M in net buying.
Recent TCON insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 14, 2023 | Opaleye Management Inc. | 10% Owner | Sale | 4.8M | $0.29 | $1.4M |
| Apr 28, 2023 | Charles Theuer | President and CEO | Purchase | 51.0K | $0.74 | $37.9K |
| Mar 13, 2023 | Opaleye Management Inc. | 10% Owner | Purchase | 174.5K | $1.38 | $240.8K |
| Mar 2, 2023 | Charles Theuer | President and CEO | Purchase | 5.0K | $1.52 | $7.6K |
| Jan 19, 2023 | Charles Theuer | President and CEO | Purchase | 6.8K | $1.62 | $11.0K |
| Jan 19, 2023 | William R Larue | Director | Sale | 120 | $1.26 | $150.64 |
| Jan 3, 2023 | Scott B. Brown | Chief Financial Officer | Purchase | 3.5K | $1.49 | $5.2K |
| Dec 16, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 167.5K | $1.25 | $209.9K |
| Dec 15, 2022 | Charles Theuer | President and CEO | Purchase | 23.0K | $1.29 | $29.8K |
| Dec 8, 2022 | Opaleye Management Inc. | 10% Owner | Sale | 1.5K | $1.44 | $2.2K |
| Nov 22, 2022 | Charles Theuer | President and CEO | Purchase | 13.9K | $1.41 | $19.6K |
| Nov 4, 2022 | Charles Theuer | President and CEO | Purchase | 9.2K | $1.52 | $14.0K |
| Nov 3, 2022 | Charles Theuer | President and CEO | Purchase | 6.0K | $1.59 | $9.5K |
| Oct 19, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 12.5K | $1.65 | $20.6K |
| Oct 11, 2022 | Charles Theuer | President and CEO | Purchase | 5.0K | $1.77 | $8.8K |
| Oct 5, 2022 | Charles Theuer | President and CEO | Purchase | 5.0K | $1.67 | $8.3K |
| Oct 3, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 9.4K | $1.74 | $16.4K |
| Sep 28, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 1.7K | $1.69 | $2.9K |
| Sep 26, 2022 | Charles Theuer | President and CEO | Purchase | 5.0K | $1.76 | $8.8K |
| Sep 22, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 17.3K | $1.73 | $29.9K |
| Sep 20, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 10.0K | $1.85 | $18.5K |
| Sep 19, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 5.0K | $1.87 | $9.4K |
| Sep 14, 2022 | Scott B. Brown | Chief Financial Officer | Purchase | 2.5K | $2.02 | $5.0K |
| Jul 26, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 2.3K | $1.72 | $3.9K |
| Jul 25, 2022 | Charles Theuer | President and CEO | Purchase | 4.5K | $1.85 | $8.3K |
Showing the 25 most recent of 91 Form 4 filings for Tracon Pharmaceuticals, Inc..
Most active TCON insiders
- Charles Theuer38 filings
- Opaleye Management Inc.35 filings
- Scott B. Brown5 filings
- Ikarian Capital, LLC4 filings
- Mark C Wiggins3 filings
Ask anything about TCON insider activity
Use Trabud's AI agent to query Tracon Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me TCON CEO purchases this year" or compare it against any other ticker.
Open the AI agentTCON insider trading FAQ
Are Tracon Pharmaceuticals, Inc. insiders buying or selling?
Across 91 SEC Form 4 filings, Tracon Pharmaceuticals, Inc. (TCON) insiders reported 87 open-market purchases totaling $13.3M and 4 sales totaling $2.5M. That is a net buying position of $10.8M.
How many insiders trade TCON stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Tracon Pharmaceuticals, Inc.. The most recent filing was accepted on Nov 14, 2023.
Where does Trabud get TCON insider trading data?
All TCON insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.